Search Results for: NeoTX

Rebooting the immune system

Israel’s NeoTX (see here previously) is now conducting a Phase 2 trial of its naptumomab estafenatox (NAP) bacteria-coated, immunotherapy cancer treatment on 30 patients in the US. It is also enhancing an AstraZeneca checkpoint inhibitor. NeoTX has 3 Nobel prizewinners … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Cancer-fighting bacteria to begin Phase 2 trials

Israel’s NeoTX Therapeutics (see here Mar 2020) has had FDA approval to begin Phase 2a human trials of its Naptumomab Estafenatox (NAP) treatment for non-small cell lung cancer. NAP binds bacteria to the tumor while activating tumor specific immune cells. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Using bacteria to fight cancer

Israel’s NeoTX uses Selective T cell Redirection (STR) technology to enlist a powerful immune response against tumors. Mutated bacteria are fused with monoclonal antibodies which target the tumor’s 5T4 antigen, alerting T-cells to kill the tumor.  NeoTX has just raised … Continue reading

Posted in Israel's Medical Achievements | Leave a comment